Home » Topics » Regulatory » Patents

Patents
RSS

Menarini prepares thrombin inhibitors

April 3, 1997

Novartis prepares PKC inhibitors

April 3, 1997

Abbott reveals compounds for controlling synaptic transmission

April 3, 1997

New thrombin inhibitors from Novartis

April 3, 1997

Vasopressin antagonists from JT

April 2, 1997

Hokuriku discloses agents for urinary incontinence

April 2, 1997

Selective CB2 receptor agonists prepared by Merck Frosst

April 2, 1997

Novel antitumor agents from Universidad Complutense

April 2, 1997

Centocor describes peptide inhibitors of selectin binding

April 2, 1997

MS&D prepares antimigraine pyrrolo-pyridine derivatives

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.